China Releases Amended Patent Examination Guidelines Focusing on Pharma and Biotech

Retrieved on: 2020-12-15 14:03:29

Tags for this article:

Patent law

Inventive step and non-obviousness

Person having ordinary skill in the art

Invention

Sulfonylurea

Click the tags to see associated articles and topics

China Releases Amended Patent Examination Guidelines Focusing on Pharma and Biotech. View article details on hiswai:

Excerpt

Claims for <b>monoclonal antibodies</b> can be defined by structural features or by the hybridoma that produces it. 【E.g】. (1) A <b>monoclonal antibody</b> against ...

Article found on: www.natlawreview.com

View Original Article